Best in Biotech 14 Nov 2025 10 gene therapy companies you should know about …resolve vaso-occlusive events and is custom-designed to treat the underlying cause of sickle cell disease, which is a complex and progressive genetic disease associated with unpredictable and debilitating vaso-occlusive events…. November 14, 2025 - 15 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 17 Jul 2025 New horizons in sickle cell disease treatment: Promising therapies on the way …they also gave the green light to bluebird bio’s Lyfgenia, another type of gene therapy. Both of the therapies produced impressive results in clinical trials. Lygenia eliminated severe vaso-occlusive events… July 17, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 26 Sep 2018 Fish Oils Finally Reel in Positive Results for Cardiovascular Disease Purified fish oil can reduce patients’ risks for adverse cardiovascular events by 25%, according to US-Irish Biotech Amarin’s Phase III trial results. The treatment, called Vascepa, significantly reduced the risk… September 26, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2023 What’s in store for biotech in 2023? Perhaps 2022 will best be remembered in the life science industry for the return of many of the face-to-face events that fell by the wayside during the COVID-19 pandemic. It… January 11, 2023 - 14 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 22 Nov 2023 Apellis’ Syfovre vs Astellas’ Izervay: the battle for a geographic atrophy treatment …participate in daily activities. In this article, we take a look at the events surrounding the historical approvals of the first two geographic atrophy treatments, and the ensuing rivalry between… November 22, 2023 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 25 Apr 2024 8 of the most expensive drugs in biopharma: Unraveling the costliest medications …production is prevented due to a mutation in the ABCD1 gene in people with CALD. This mutation prevents the breakdown of very long-chain fatty acids and ultimately resulting in destruction… April 25, 2024 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 13 Nov 2017 Spanish Biotech Gets €2.4M to Spot Myocardial Infarction Before it’s Too Late …of its first diagnostic tool. Acute ischemic events like myocardial infarction are one of the most common cardiac emergencies, causing over 1.7 million deaths in Europe each year. Early detection… November 13, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 17 Oct 2022 Positive results from Milestone Pharmaceuticals’ phase 3 PSVT trial …RAPID trial continue to support the potential self-use of etripamil, with findings consistent with those observed in prior trials. The most common randomized treatment emergent adverse events (RTEAEs), adverse events… October 17, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 16 Aug 2022 Viridian reports positive news from ongoing trial for patients with Thyroid Eye Disease …20mg/kg of VRDN-001, no adverse events of hyperglycemia, muscle spasm, hearing impairment, infusion reactions, or any serious adverse events were reported as of the cutoff date of August 9, 2022…. August 16, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Expert Advice 14 Jun 2024 Biotech valuation multiples: how to value a biotech company? …no single formula that can condense the multiple parameters influencing a biotech stock — market potential, cash burn rate, the management team, business strategy, intellectual property, and even unpredictable events… June 14, 2024 - 12 minutesmins - By Carlos de Rojas Share WhatsApp Twitter Linkedin Email
News and Trends 24 Jun 2022 Stramsen Biotech to look at 11 plant-based drug candidates …are safe, effective and currently in use in different countries. The drug candidates are: SBX 1052, which controls/prevents enlargement of the prostate glands; SBX1968, which controls/prevents the proliferation and metastasis… June 24, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 23 Mar 2023 Intracellular “smoke detector” discovery has skin disease therapy implications …cells. Fire alarm prevents long-lasting smoldering fire “This process is hugely important,” said Latz, who is also the spokesperson for the Cluster of Excellence ImmunoSensation2 and a member of the… March 23, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email